Electrical Engineer 2

How EMS agencies can use technology to drive timely patient payments. New patient statement and payment portal centralizes billing, statements, and online payments in a single, time-saving solution. ZOLL(R) and healthcare payment platform, PayGround, are teaming up to modernize EMS patient billing and payment processes. Running individual patient statements takes up valuable time for EMS billing staff during business hours. Printing, folding, stuffing, and mailing paper statements is inefficient and costly. Many patients want to pay by credit card (FSA or private account), but for EMS agencies to be able to accept patient credit card payments, they traditionally need to enroll with a credit card payment processor. The collaboration between ZOLL and PayGround enables ZOLL Billing customers to streamline workflows and improve billing performance through a single, time-saving solution. The digital-first patient statement and payment portal automates paperless statement generation and credit card processing to reduce manual effort, help improve timely payments, and enhance cash flow predictability. According to industry data, more than 13 percent of EMS services are unpaid or self-paid, leaving nearly $4.5 billion on the table every year.[1] Patients are more likely to pay on time if they have online payment options, but having to enroll with a separate credit card payment processor to accept patient credit card payments creates another layer of complexity and administrative burden for EMS agencies. Now, billing, patient statements, and online payment processing are centralized in a single solution, ZOLL Billing - increasing the likelihood of timely patient payments. Payment status can be tracked by claim, which helps billing staff predict cash flow. "EMS organizations struggle with the staggering costs of uncompensated care. The ZOLL Billing and PayGround integration will help address this massive financial friction point," said Drew Mercer, CEO of PayGround. "We are thrilled to work with ZOLL to help bring technological advances to the industry." For many ZOLL customers, the integration represents their first opportunity to offer digital payment options to patients. "ZOLL EMS customers operate in a demanding, high-performance, low-reimbursement environment where every dollar matters," said Stacey Bickford, Senior Product Manager at ZOLL. "We strive to support EMS agencies at every stage of operations with advanced products that help them do their jobs better, with less effort, so they can focus on fulfilling their life-saving mission. This labor-saving integration with PayGround helps agencies improve financial and operational performance efficiently while enhancing the patient financial experience and overall satisfaction with their EMS encounter." If you have questions or would like to learn more about the offerings related to the collaboration, please contact ZOLL Data Systems, Inc. online or call ZOLL Data Systems, Inc. at 800-474-4489. [1] naemt.org, https://naemt.org/docs/default-source/home-page-docs/national-survey-on-uncompensated-care-in-ems.pdf?sfvrsn=83d3f093_1. Accessed 17 April 2026. Was this information valuable? May 29, 2026 EMS billing has run the same way for decades. A claim adjudicates, a paper statement goes out, and the agency waits - 30 to 60 days,... Mar 26, 2026 Your local EMS system got a rare gift last year: a budget increase. Now, though, council members want to make sure their funds were well... Mar 3, 2026 The 43-day shutdown of the U.S. government in October and November 2025 complicated things for many businesses, and that included the... ZOLL pulse blog. Subscribe to its blog and receive quality content that makes your job as an EMS & fire, hospital, or AR professional easier.

ZOLL, an Asahi Kasei company manufacturing medical devices, has announced that its Zenix monitor/defibrillator received approval under the European Union Medical Device Regulation 2017/745. The device is designed for use in both emergency medical services and hospital settings. Zenix features a large touchscreen and on-the-fly customisation capabilities, allowing healthcare professionals to make real-time adjustments during critical situations. The device incorporates ZOLL's Real BVM Help and Real CPR Help technology, providing clinical feedback to improve ventilation quality and CPR delivery. According to Elijah White, president of ZOLL Acute Care Technology, virtually all device functions are accessible with three screen-touches or fewer. Zenix joins ZOLL's existing portfolio of professional monitors and defibrillators, including the X Series, R Series and M2 models.

ZOLL medical appoints Eric Knudsen as new CEO. CHELMSFORD, Mass. - (BUSINESS WIRE) - ZOLL(R), an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it has appointed Eric Knudsen as its new Chief Executive Officer, effective April 1. Knudsen will succeed Jon Rennert, who served as ZOLL's CEO for the past 10 years and will assume a new role as Executive Chairman of ZOLL's Board of Directors. "As a global leader in medical technology, ZOLL is continually looking for ways to expand our business and reach more patients in need," said Rennert. "Eric has played a unique role in developing our growth strategies and driving our expansion, and I am confident he will lead ZOLL to even greater growth and success." "I am honored to become ZOLL's next CEO," said Knudsen. "ZOLL has a long legacy of innovation and clinical excellence, and today our medical devices, software, and related services are used worldwide to diagnose and treat patients suffering from serious cardiopulmonary and respiratory conditions. We will continue to lead with our commitment to patients and customers and our passion for improving outcomes and helping save lives." Knudsen has nearly 30 years of experience in the medtech industry, with deep expertise in business development and corporate strategy. He led ZOLL's Corporate Development team for six years and was responsible for investing in strategic relationships and acquiring more than a dozen new technologies. For the past four years, Knudsen was President of ZOLL Itamar, a division of ZOLL that is focused on the diagnosis of sleep disorders. Knudsen led the division through significant growth and a dramatic increase in profitability. Prior to joining ZOLL in 2013, Knudsen held leadership positions in international sales, marketing, and manufacturing partnerships at Covidien (now Medtronic), Aspect Medical Systems, and LeMaitre Vascular. He has an MBA from the Thunderbird School of Global Management and a bachelor's degree from Boston College. Rennert was named CEO of ZOLL in 2016, after serving as President of the company's largest business unit for eight years. Under Rennert's leadership as CEO, ZOLL expanded its reach as a global leader in external defibrillation, pioneered novel solutions for patients with serious cardiopulmonary and respiratory conditions, and significantly broadened its portfolio of products. About ZOLL ZOLL, an Asahi Kasei company, develops and markets medical devices and software solutions that help advance care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and cardiac monitoring, circulation enhancement and CPR feedback, supersaturated oxygen therapy, data management, ventilation, therapeutic temperature management, and sleep apnea diagnosis and treatment, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, as well as lay rescuers, improve patient outcomes in critical cardiopulmonary conditions. For more information, visit www.zoll.com. About Asahi Kasei The Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber businesses, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With 50,000 employees worldwide, the company contributes to a sustainable society by providing solutions to the world's challenges through its three business sectors of Healthcare, Homes, and Material. Its healthcare operations include devices and systems for critical care, products and services for the manufacture of biotherapeutics, and a growing portfolio of specialty pharmaceuticals. For more information, visit www.asahi-kasei.com. Asahi Kasei is also dedicated to sustainability initiatives and is contributing to reaching a carbon neutral society by 2050. To learn more, visit https://www.asahi-kasei.com/sustainability/. Matt Hogan ZOLL 978-805-6561 [email protected]